Talukdar, Fazlur Rahman; di Pietro, Massimiliano; Secrier, Maria et al.
Molecular landscape of esophageal cancer: implications for early detection and personalized therapyANNALS OF THE NEW YORK ACADEMY OF SCIENCES. Bd. 1434. H. 1. 2018 S. 342-359
Buzdin, A; Sorokin, M; Garazha, A et al.
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugsSeminars in Cancer Biology. 2018 S. 1-15
Grothe, Michel J.; Sepulcre, Jorge; Gonzalez-Escamilla, Gabriel et al.
Molecular properties underlying regional vulnerability to Alzheimer's disease pathologyBRAIN. Bd. 141. 2018 S. 2755-2771
Deng, Maximilian Y.; Sill, Martin; Chiang, Jason et al.
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresACTA NEUROPATHOLOGICA. Bd. 136. H. 2. 2018 S. 239-253
Ellwardt, Erik; Ellwardt, Lea; Bittner, Stefan et al.
Monitoring B-cell repopulation after depletion therapy in neurologic patientsNEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. Bd. 5. H. 4. 2018
Negwer, Inka; Best, Andreas; Schinnerer, Meike et al.
Monitoring drug nanocarriers in human blood by near-infrared fluorescence correlation spectroscopyNATURE COMMUNICATIONS. Bd. 9. 2018
Rosigkeit, Sebastian; Meng, Martin; Grunwitz, Christian et al.
Monitoring Translation Activity of mRNA-Loaded Nanoparticles in MiceMOLECULAR PHARMACEUTICS. Bd. 15. H. 9. 2018 S. 3909-3919
Raker, V. K.; Haub, J.; Lorenz, N. et al.
Monocyte recruitment and monocyte/platelet cluster formation in systemic sclerosisEXPERIMENTAL DERMATOLOGY. Bd. 27. H. 3. 2018 S. E46-E46
Borgmann, Hendrik; Lallous, Nada; Ozistanbullu, Deniz et al.
Moving Towards Precision Urologic Oncology: Targeting Enzalutamide-resistant Prostate Cancer and Mutated Forms of the Androgen Receptor Using the Novel Inhibitor Darolutamide (ODM-201)EUROPEAN UROLOGY. Bd. 73. H. 1. 2018 S. 4-8
Hassan, Zonera; Schneeweis, Christian; Wirth, Matthias et al.
MTOR inhibitor-based combination therapies for pancreatic cancerBRITISH JOURNAL OF CANCER. Bd. 118. H. 3. 2018 S. 366-377